Category: Uncategorized

  • NMH, RIC to lease VA Site

    NMH, RIC to Lease VA Land Northwestern Memorial Hospital (NMH) and the Rehabilitation Institute of Chicago (RIC) are one step closer to leasing the land occupied by the former VA Lakeside Medical Center (VALMC). During a formal ceremony on January 18 in Washington, NMH and RIC officials met with Secretary of Veterans Affairs Anthony J.…

  • Superior Street Water Main Project Starts

    Superior Street Water Main Project StartsWhen the City of Chicago first installed the water main pipe that currently runs below Superior Street—between Lake Shore Drive and Fairbanks Court—traffic jams may have involved as many horses and carriages as cars. In place since 1911, the existing 8-inch pipe will soon be replaced with a larger, 12-inch…

  • Aspirin Underused in Diabetic Women, Young Adults

    Aspirin Underused in Diabetic Women, Young Adults CHICAGO—Cardiovascular disease risk is extremely high in adults with diabetes. Yet women as well as people under 50 who have diabetes do not use aspirin, despite the fact that aspirin has been found an effective and inexpensive means to reduce risk of first and subsequent heart attack. Previous…

  • Magnetic Resonance Imaging Deconstructs Brain’s Complex Network

    January 4, 2005 Magnetic Resonance Imaging Deconstructs Brain’s Complex Network CHICAGO—A team headed by scientists at Northwestern University, using functional magnetic resonance imaging (fMRI), has shown how to visualize the human brain as a massive, interacting, complex network governed by a few underlying dynamic principles. The research opens fascinating possibilities for future basic and applied…

  • Feinberg School Has Role in New Breast Cancer Drug

    Feinberg School Has Role in New Breast Cancer DrugResearch at Northwestern University’s Feinberg School of Medicine played a significant role in Food and Drug Administration approval of AbraxaneTM (paclitaxel protein-bound particles for injectable suspension) for the treatment of metastatic breast cancer. “The approval means that women with metastatic breast cancer no longer need to endure…

  • Toxicities and Off-Label Use of Cancer Drugs

    Toxicities and Off-Label Use of Cancer DrugsBy Elizabeth Crown CHICAGO—Food and Drug Administration policies prevent pharmaceutical manufacturers from informing patients about potentially fatal toxicities that occur with some cancer drugs—policies that should be revised immediately, according to Northwestern University researchers. Andrew M. Evens, DO, instructor in medicine, and Charles L. Bennett, MD, PhD, professor of…

  • Adverse Events in Hospitalized Children Are Preventable

    Adverse Events in Hospitalized Children Are Preventable By Elizabeth Crown A study by researchers at Northwestern University’s Feinberg School of Medicine suggests that each year nearly 70,000 children hospitalized in the United States experience an adverse event and that at least 60 percent of these errors may be preventable. Adverse events are injuries caused by…

  • Daily Activity Helps Elderly Cognition

    December 21, 2004 Daily Activity Helps Elderly Cognition CHICAGO—More than half of adults over the age of 65 have trouble sleeping, characterized by both lighter sleep and frequent awakenings during the night. A decline in cognitive function is common with advanced age, and research has shown that disturbed sleep in younger adults and in the…

  • Research Studies Drug to Treat Brain Metastases

    Research Studies Drug to Treat Brain Metastases CHICAGO—A Northwestern University cancer researcher is conducting a study that will compare the effects of whole brain radiation therapy with supplemental oxygen without or with EfaproxynTM (efaproxiral), an experimental radiation sensitizer, in participants with brain cancer originating from metastatic breast cancer. It is believed that efaproxiral may improve…

  • Research Seeks to Advance Diabetes Treatment

    Research Seeks to Advance Diabetes Treatment CHICAGO—Northwestern University has received a major grant from the Juvenile Diabetes Research Foundation (JDRF) to advance technologies in the field of islet cell replacement for the treatment of Type 1 diabetes. Principal investigator on the $1.5 million JDRF program project is Dixon B. Kaufman, MD, PhD, professor and vice…